UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007971
Receipt number R000009384
Scientific Title Efficacy of Helicobacter pylori eradication regimen based on antibiotic susceptibility testing in patients with multiple eradication failures
Date of disclosure of the study information 2012/05/16
Last modified on 2016/09/20 22:25:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of Helicobacter pylori eradication regimen based on antibiotic susceptibility testing in patients with multiple eradication failures

Acronym

Efficacy of Helicobacter pylori eradication regimen based on antibiotic susceptibility testing

Scientific Title

Efficacy of Helicobacter pylori eradication regimen based on antibiotic susceptibility testing in patients with multiple eradication failures

Scientific Title:Acronym

Efficacy of Helicobacter pylori eradication regimen based on antibiotic susceptibility testing

Region

Japan


Condition

Condition

Patients with multiple eradication failures

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy of antibiotic susceptibility testing based Helicobacter eradication therapy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Efficacy of Hp eradication

Key secondary outcomes

Eradication rate of different regimen
Frequency of adverse effects


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Third line eradication therapy with esomeprazole, amoxicillin, and sitafloxacin
Rescue therapy based on antibiotic susceptibility testing

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Patients with past history of peptic ulcer, gastric MALT lymphoma, and early gastric cancer treated by endoscopic resection
2. Patients positive for H. pylori infection
3. Patients with two eradication failures by clarithromycin- and metronidazole-based regimen


Key exclusion criteria

1. Pregnancy
2. Lactation
3. Past history of allergy for the drugs used in this study.
4. Severe other organ dysfunction
5. Patients who are disqualified for the study by their physicians

Target sample size

26


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshihiro Hirata

Organization

The University of Tokyo Hospital

Division name

Department of Gastroenterology

Zip code


Address

7-3-1, Hongo, Bunkyo-ku, Tokyo

TEL

03-3815-5411

Email

hiratay-int@h.u-tokyo.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yoshihiro Hirata

Organization

The University of Tokyo Hospital

Division name

Department of Gastroenterology

Zip code


Address

7-3-1, Hongo, Bunkyo-ku, Tokyo

TEL

03-3815-5411(33070)

Homepage URL


Email

hiratay-int@h.u-tokyo.ac.jp


Sponsor or person

Institute

Department of Gastroenterology, The University of Tokyo

Institute

Department

Personal name



Funding Source

Organization

Department of Gastroenterology, The University of Tokyo

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 05 Month 16 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

http://dx.doi.org/10.1016/j.ijid.2016.08.019

Number of participants that the trial has enrolled


Results

All 30 patients completed the study. Eradication was successful in 25 patients and the eradication rate was 83% in the intention-to-treat and per-protocol analyses. No specific or significant adverse events were recorded in the 30 patients. Patient characteristics such as gender, body mass index, and pepsinogen I/II ratio did not differ between patients who were successfully treated and those who were not successfully treated.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 04 Month 27 Day

Date of IRB


Anticipated trial start date

2012 Year 05 Month 01 Day

Last follow-up date

2015 Year 12 Month 31 Day

Date of closure to data entry

2016 Year 03 Month 31 Day

Date trial data considered complete

2016 Year 03 Month 31 Day

Date analysis concluded

2016 Year 08 Month 19 Day


Other

Other related information



Management information

Registered date

2012 Year 05 Month 16 Day

Last modified on

2016 Year 09 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009384


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name